NURS FPX 4015 Assessment 3 Mental Health Diagnosis Concept Map example

Reviewed by Odette Lachlan, MSN, RN Pathophysiology, Pharmacology, and Physical Assessment Capella University Free custom sample in 24 to 48h

This NURS FPX 4015 Assessment 3 sample paper is a concept map with a written narrative for a 38-year-old woman with major depressive disorder. It comes from Capella NURS FPX 4015, the RN-to-BSN course NURS-FPX4015, where the third assessment moves the 3Ps into mental health care. The map starts from a central patient node and branches into pathophysiology, pharmacology and assessment, with every arrow stated in words so a reader can follow the reasoning. The branches converge on ranked nursing diagnoses, each tied to interventions and measurable outcomes, and a short narrative explains the two links that matter most for her safety and recovery. The map, the narrative and the references are all reproduced on this page, preceded by a table of the basics.

CourseNURS FPX 4015 Pathophysiology, Pharmacology, and Physical Assessment
AssessmentAssessment 3
Paper typeConcept map with narrative
LengthAbout 1,100 words, 5 pages
FormatAPA 7 student paper
SchoolCapella University
ProgramRN-to-BSN (BSN)
UpdatedSeptember 2026

Free sample paper for NURS FPX 4015 Assessment 3

1

Concept Map: The 3Ps and Mental Health Care for a 38-Year-Old Woman With Major Depressive Disorder

Student Name

Capella University

NURS FPX 4015: Pathophysiology, Pharmacology, and Physical Assessment

Instructor Name

Month Day, Year

What this part is doingThe title names the patient and the diagnosis. A concept map is judged on connections, so the title commits the map to one person before the first node appears.
2

Introduction

A concept map shows relationships that a paragraph can hide. This map connects the three Ps, pathophysiology, pharmacology, and physical assessment, to the nursing care of one composite patient with major depressive disorder (MDD). Because the map must be read here as text, each node is written with its content followed by the nodes it points to. A short narrative after the map explains its most important links.

Central Node: The Patient

Ms. L. is a 38-year-old accountant who presents to an outpatient behavioral health clinic after her primary care provider found a Patient Health Questionnaire-9 (PHQ-9) score of 19. For two months she has felt flat and sad on most days, has stopped running and cooking, which she used to enjoy, and describes early morning waking at 4 a.m., a 4 kg weight loss, poor concentration at work, and feelings of worthlessness. She has no history of mania. She meets the criteria for major depressive disorder, single episode, moderately severe (American Psychiatric Association, 2022). She is a composite built for teaching; no real patient is described. Points to: Pathophysiology, Pharmacology, Assessment.

What this part is doingThe central node states the diagnosis and the evidence for it in the patient's own symptoms. Every branch that follows should trace back to something in this node, which is how a scorer checks that the map is about this patient.
3

Pathophysiology Branch

Node P1, Monoamine and stress-system changes: MDD is associated with altered serotonin and norepinephrine signaling and with a dysregulated hypothalamic-pituitary-adrenal axis, including elevated cortisol. The monoamine explanation is incomplete, because drugs raise synaptic serotonin within hours while mood improves over weeks. Points to: P2, Pharm1. Node P2, Neuroplasticity: current models emphasize reduced neuroplasticity in regions that regulate mood, such as the hippocampus and prefrontal cortex. Antidepressant effects are thought to depend on gradual changes in receptor sensitivity and synaptic growth, which explains why response takes two to six weeks. Points to: Pharm2, ND2. Node P3, Symptoms as expressions of the mechanism: early morning waking and weight loss reflect disrupted circadian and appetite regulation; poor concentration reflects prefrontal changes. Points to: A1, ND3.

Pharmacology Branch

Node Pharm1, Sertraline 50 mg daily: a selective serotonin reuptake inhibitor (SSRI) that blocks serotonin reuptake. SSRIs are first-line because of their balance of efficacy and tolerability; a network meta-analysis of 522 trials found all 21 antidepressants studied more effective than placebo for adults with MDD, with sertraline among those with favorable acceptability (Cipriani et al., 2018). Points to: Pharm2, Pharm3. Node Pharm2, Expected timeline: side effects appear first, benefit later. Nausea, headache, and sleep changes are common in the first two weeks. Points to: ND2, Teaching. Node Pharm3, Safety: the United States labeling of all antidepressants carries a boxed warning about increased suicidal thinking in people younger than 25. Ms. L. is older than that group, yet the first weeks of treatment still call for close monitoring, and serotonin syndrome is possible if other serotonergic drugs, including some migraine medications and supplements, are added. Points to: A2, ND1.

What this part is doingEach drug node is connected to the mechanism node it acts on and to the risk it creates. That two-way linking is what separates a concept map from a drug card.
4

Assessment Branch

Node A1, Mental status examination: appearance neat but tired; psychomotor slowing; speech soft and slow; mood "empty"; affect constricted; thought process logical; no psychotic features; insight and judgment intact. Points to: ND2, ND3. Node A2, Suicide risk: screened with the Columbia-Suicide Severity Rating Scale (Posner et al., 2011). She endorses passive wishes to be dead on some days, with no plan, intent, or preparatory behavior, and no past attempts. Protective factors: close sister, no firearms at home, commitment to her dog. Points to: ND1. Node A3, Measurement over time: PHQ-9 repeated every two weeks; a reduction of 50% or more indicates response (Kroenke et al., 2001). Physical assessment includes weight, sleep hours, and vital signs, since weight loss and insomnia are both symptoms and treatment targets. Points to: Outcomes.

Nursing Diagnoses, Interventions, and Outcomes

Node ND1, Risk for suicide, related to depressed mood and passive death wishes, first priority. Interventions: collaborative safety plan listing warning signs, coping steps, and contacts, including the 988 Suicide and Crisis Lifeline; follow-up call within one week. Outcome: Ms. L. identifies three warning signs and two contacts and reports no suicidal intent at each visit. Node ND2, Hopelessness, related to slow response to treatment. Interventions: explain the timeline in Pharm2 so early side effects are not read as failure; set a small daily activity goal such as a ten-minute walk. Outcome: continues sertraline through week six; PHQ-9 falls at least 50% by week eight. Node ND3, Disturbed sleep pattern, related to early morning waking. Interventions: fixed wake time, limit daytime napping, avoid alcohol. Outcome: reports at least six hours of sleep on five nights a week by week four. Teaching node: take sertraline in the morning with food; do not stop suddenly, because abrupt discontinuation can cause dizziness, irritability, and flu-like symptoms; avoid adding over-the-counter supplements such as St. John's wort; report agitation, worsening mood, or new thoughts of self-harm immediately. Points to: ND2, Outcomes.

Node Collaboration, the team around the plan: the psychiatric nurse practitioner adjusts the dose at week four if the PHQ-9 has fallen by less than 25%; a therapist offers cognitive behavioral therapy, since combined medication and psychotherapy is more effective than either alone for many adults with moderate depression; the primary care provider follows weight and any new physical complaints. Ms. L. agreed to let the clinic speak with her sister, who will drive her to the first two visits. Points to: ND1, ND2, Outcomes.

Node Outcomes, how the map will be judged at week eight: PHQ-9 at or below 9, no suicidal ideation, six or more hours of sleep on most nights, weight stable or rising, and a return to one valued activity such as a weekly run. Each outcome traces back to a symptom named in the central node, which closes the map.

Narrative: The Two Links That Matter Most

Two connections drive this map. The first runs from P2 through Pharm2 to ND2. Because antidepressants act through slow neuroplastic change, the first weeks bring side effects without benefit, which is the exact period when patients most often stop treatment and when hopelessness is highest. Teaching the timeline is therefore not a courtesy; it is an intervention grounded in pathophysiology. The second link runs from Pharm3 and A2 to ND1. A patient beginning treatment for depression needs a structured suicide risk assessment and a safety plan at the start, not only when she seems worse, because risk can change as energy returns before mood does. The three Ps together explain why the first eight weeks are both the most promising and the most dangerous part of Ms. L.'s care.

What this part is doingThe narrative explains the reasoning behind two arrows instead of summarizing the whole map. Scorers use this section to see whether the student understands why the nodes connect, which is the purpose of the assignment.
5

References

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Publishing.

Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., Egger, M., Takeshima, N., Hayasaka, Y., Imai, H., Shinohara, K., Tajika, A., Ioannidis, J. P. A., & Geddes, J. R. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. The Lancet, 391(10128), 1357-1366. https://doi.org/10.1176/appi.focus.16407

Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606-613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x

Posner, K., Brown, G. K., Stanley, B., Brent, D. A., Yershova, K. V., Oquendo, M. A., Currier, G. W., Melvin, G. A., Greenhill, L., Shen, S., & Mann, J. J. (2011). The Columbia-Suicide Severity Rating Scale: Initial validity and internal consistency findings from three multisite studies with adolescents and adults. American Journal of Psychiatry, 168(12), 1266-1277. https://doi.org/10.1176/appi.ajp.2011.10111704

The Capella NURS FPX 4015 Assessment 3 instructions

The instructions ask you to build a concept map for a patient with a mental health diagnosis that shows how pathophysiology, pharmacology and physical and mental status assessment connect, and to support it with a narrative and scholarly sources. The map should include the patient's presenting data, the disease process, the medications and their effects, the assessment findings, prioritized nursing diagnoses, interventions and expected outcomes. Most students create the diagram in a drawing tool and submit it with an explanatory paper in APA format. You choose the diagnosis in most versions; depression, generalized anxiety and bipolar disorder are common choices with solid evidence. The paper around the map does not need to be long, and the sample runs about 1,100 words, but every connection has to be explained.

How the NURS-FPX4015 Assessment 3 example is put together

The map begins with the central patient node, then branches into three groups for the three Ps, each written as a node with its arrows stated in words so a reader can follow every connection. The branches converge on prioritized nursing diagnoses, each linked to interventions and measurable outcomes. A short narrative after the map explains the two most important links, which is where the reasoning behind the map is scored.

NURS FPX 4015 Assessment 3 scoring guide: what Distinguished looks like

The scoring guide reads the map for connections, not boxes. Proficient maps show the right content; Distinguished maps link each node to the ones it affects and say why, for instance a drug node connected both to the mechanism it acts on and to the risk it creates. The diagnosis criterion rewards two or three nursing diagnoses ranked by priority with measurable outcomes. The narrative criterion is where the reasoning is graded: explaining the logic of two key links in depth scores better than summarizing every node. Safety matters in mental health maps, so suicide risk assessment and medication safety should appear where they belong. Sources, clarity and APA format close out the guide, and the annotations beside the map flag the linking moves that score highest.

NURS FPX 4015 Assessment 3 help from the desk

Students often submit a drug card in map form, with nodes that describe but never connect. Another frequent problem is too many nursing diagnoses; beyond three, the map turns into a list and priority is lost. Some maps leave out mental status findings and include only physical assessment, which misses half the assessment branch for a psychiatric diagnosis. The narrative also gets rushed. It should explain reasoning, not repeat the map in sentences. Keep drug information current, including boxed warnings where they apply, and cite it. Finally, make sure the image is readable when exported; a map the scorer cannot zoom into cannot score well. The desk writes free custom maps for other diagnoses on request.

Get a NURS FPX 4015 Assessment 3 example written to your instructions

Send the Assessment 3 instructions, your scoring guide and any template your courseroom supplies, and a custom example is written into it at the level of specificity the criteria reward, in 24 to 48 hours. The first one is free and the examination stays yours to perform. The paper above is an original model document written by our desk, not a submitted student paper and not an official Capella University document.

More NURS FPX 4015 papers and RN-to-BSN samples

NURS FPX 4015 Assessment 3 questions, answered

How do I present a concept map in a paper for NURS FPX 4015 Assessment 3?

Most students build the map in a diagram tool and attach it, then add a written explanation. When the map has to be read as text, write each node with its content and state its arrows in words, as the sample does, so the connections survive without the drawing.

Which mental health diagnosis should I choose?

One common enough that current evidence and first-line treatments are well established, such as major depressive disorder, generalized anxiety disorder, or bipolar disorder. The sample uses depression because the SSRI mechanism and the risk assessment connect clearly.

How many nursing diagnoses should the map include?

Two or three, ranked. More than that usually means the map has become a list, and the scorer cannot see which problem drives the plan.

Where can I find a free NURS FPX 4015 Assessment 3 sample paper?

The full concept map and narrative for the patient with major depressive disorder are on this page, with references and margin notes on the linking moves. A free custom sample for your own diagnosis is available through the request form.

Can the NURS FPX 4015 Assessment 3 concept map be a table instead of a diagram?

Check your courseroom, but most versions expect a visual map with arrows. The sample presents the map node by node in text so it reads on the page; in your submission, build the diagram and keep the written narrative beside it.